All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancer
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf082 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Shaikha Al-Thani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES Compare oncologic outcomes between single-segment and multi-segment resections in patients with clinical stage IA1 and IA2 non-small-cell lung cancer. METHODS A retrospective review (2011–2022) was conducted using a prospectively maintained database. Patients undergoing anatomical segmentectomy for clinical stage IA ≤2 cm non-small-cell lung cancers were included. Patients were grouped into single-segment and multi-segment resections. Patients were excluded if they had neuroendocrine tumours, small-cell lung cancer, underwent wedge resection or lobectomy. The primary outcome was locoregional recurrence. Secondary outcomes of disease-free survival, locoregional recurrence-free survival, overall survival, pathologic upstaging and perioperative complications were evaluated. RESULTS One hundred ninety (63.8%) patients had single-segment resection and 108 (36.2%) had multi-segment resection. The single-segment resection group had smaller tumours (1.3 vs 1.45 cm, P = 0.02), but no significant difference in margin length (1.7 vs 2 cm, P = 0.15). Fewer lymph nodes were resected in single-segment resection (7 vs 10, P < 0.001), and a significantly lower rate of pathologic upstaging (4.2% vs 10.2%, P = 0.03) was observed compared with multi-segment resection. Nevertheless, locoregional recurrence developed in 6.3% of patients after single-segment resection and 7.4% patients following multi-segment resection (P = 0.72). With a median follow-up duration of 40 months, 5-year disease-free survival, locoregional recurrence-free survival and overall survival was 73, 89 and 87% following single-segment resection compared to 78, 95 and 84% after multi-segment resection. CONCLUSIONS For patients with clinical stage IA non-small cell lung cancers ≤2 cm, locoregional recurrence and survival are not different based on whether patients receive a single-segment or multi-segment resection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA.
ORCID-Profile: Oliver S Chow
Zitieren
APA
Al-Thani, S., Nasar, A., Villena-Vargas, J., Harrison, S., Lee, B., Port, J. L., Altorki, N., & Chow, O. S. (2025). All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf082
Vancouver
Al-Thani S, Nasar A, Villena-Vargas J, Harrison S, Lee B, Port JL, et al. All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf082
BibTeX
@article{AlThani2025,
author = {Al-Thani, Shaikha and Nasar, Abu and Villena-Vargas, Jonathan and Harrison, Sebron and Lee, Benjamin and Port, Jeffrey L and Altorki, Nasser and Chow, Oliver S},
title = {All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancer},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf082}
}
EUVIMED